Reversal, maintenance or progression: What happens to the liver after a virologic cure of hepatitis C?

作者: Youngmin A. Lee , Scott L. Friedman

DOI: 10.1016/J.ANTIVIRAL.2014.03.012

关键词:

摘要: A sustained virological response (SVR) from HCV (synonymous with cure) leads to decreased mortality, morbidity and improved quality of life, as well a reduced incidence liver disease progression, including failure, cirrhosis hepatocellular carcinoma. Large clinical trials comparing pre- post-treatment biopsies demonstrate improvements in inflammation fibrosis score following SVR. However, small subset patients display persistent hepatic and/or progress despite In addition conferring risk advanced pre-treatment is major factor for post-SVR this review, we discuss the mechanisms regression uncovered using experimental models highlight potential those few progression We also introduce current concepts fibrosis-dependent tumorigenesis disease. This article forms part symposium Antiviral Research on “Hepatitis C: next steps toward global eradication.”

参考文章(115)
J P Iredale, R C Benyon, J Pickering, M McCullen, M Northrop, S Pawley, C Hovell, M J Arthur, Mechanisms of spontaneous resolution of rat liver fibrosis. Hepatic stellate cell apoptosis and reduced hepatic expression of metalloproteinase inhibitors. Journal of Clinical Investigation. ,vol. 102, pp. 538- 549 ,(1998) , 10.1172/JCI1018
Sarah L. George, Bruce R. Bacon, Elizabeth M. Brunt, Kusal L. Mihindukulasuriya, Joyce Hoffmann, Adrian M. Di Bisceglie, Clinical, virologic, histologic, and biochemical outcomes after successful HCV therapy: a 5-year follow-up of 150 patients. Hepatology. ,vol. 49, pp. 729- 738 ,(2009) , 10.1002/HEP.22694
Evaggelia Liaskou, Daisy V. Wilson, Ye H. Oo, Innate immune cells in liver inflammation. Mediators of Inflammation. ,vol. 2012, pp. 949157- 949157 ,(2012) , 10.1155/2012/949157
John A Mengshol, Lucy Golden-Mason, Hugo R Rosen, Mechanisms of Disease: HCV-induced liver injury. Nature Clinical Practice Gastroenterology & Hepatology. ,vol. 4, pp. 622- 634 ,(2007) , 10.1038/NCPGASTHEP0961
V. Ramakrishnaiah, C. Thumann, I. Fofana, F. Habersetzer, Q. Pan, P. E. de Ruiter, R. Willemsen, J. A. A. Demmers, V. Stalin Raj, G. Jenster, J. Kwekkeboom, H. W. Tilanus, B. L. Haagmans, T. F. Baumert, L. J. W. van der Laan, Exosome-mediated transmission of hepatitis C virus between human hepatoma Huh7.5 cells Proceedings of the National Academy of Sciences of the United States of America. ,vol. 110, pp. 13109- 13113 ,(2013) , 10.1073/PNAS.1221899110
C.-J. CHU, S.-D. LEE, T.-H. HUNG, H.-C. LIN, S.-J. HWANG, F.-Y. LEE, R.-H. LU, M.-I. YU, C.-Y. CHANG, P.-L. YANG, C.-Y. LEE, F.-Y. CHANG, Insulin resistance is a major determinant of sustained virological response in genotype 1 chronic hepatitis C patients receiving peginterferon α‐2b plus ribavirin Alimentary Pharmacology & Therapeutics. ,vol. 29, pp. 46- 54 ,(2009) , 10.1111/J.1365-2036.2008.03823.X
Luca Valenti, MariaGrazia Rumi, Enrico Galmozzi, Alessio Aghemo, Benedetta Del Menico, Stella De Nicola, Paola Dongiovanni, Marco Maggioni, Anna Ludovica Fracanzani, Raffaela Rametta, Massimo Colombo, Silvia Fargion, Patatin‐Like phospholipase domain‐containing 3 I148M polymorphism, steatosis, and liver damage in chronic hepatitis C Hepatology. ,vol. 53, pp. 791- 799 ,(2011) , 10.1002/HEP.24123
Hossein Poustchi, Francesco Negro, Jason Hui, Ian Homer Y. Cua, Laura Rubbia Brandt, James G. Kench, Jacob George, Insulin resistance and response to therapy in patients infected with chronic hepatitis C virus genotypes 2 and 3 Journal of Hepatology. ,vol. 48, pp. 28- 34 ,(2008) , 10.1016/J.JHEP.2007.07.026
Yujin Hoshida, Augusto Villanueva, Masahiro Kobayashi, Judit Peix, Derek Y. Chiang, Amy Camargo, Supriya Gupta, Jamie Moore, Matthew J. Wrobel, Jim Lerner, Michael Reich, Jennifer A. Chan, Jonathan N. Glickman, Kenji Ikeda, Masaji Hashimoto, Goro Watanabe, Maria G. Daidone, Sasan Roayaie, Myron Schwartz, Swan Thung, Helga B. Salvesen, Stacey Gabriel, Vincenzo Mazzaferro, Jordi Bruix, Scott L. Friedman, Hiromitsu Kumada, Josep M. Llovet, Todd R. Golub, Gene Expression in Fixed Tissues and Outcome in Hepatocellular Carcinoma The New England Journal of Medicine. ,vol. 359, pp. 1995- 2004 ,(2008) , 10.1056/NEJMOA0804525